THE Pharmacy Board of Australia is planning further engagement with the Australian Medical Association (AMA) and the Royal Australian College of General Practitioners (RACGP) around its proposal for pharmacy prescribing.
The doctors' groups last week accused the Board of suppressing debate on the issue (PD 07 Nov), but a spokesperson for the board has told Pharmacy Daily that further opportunities for consultation and engagement are planned, including an open public consultation scheduled to commence late this year and continue into early 2026.
"The Board is committed to a transparent and inclusive consultation that recognises the important voice of the medical profession and our shared interest in the safety and quality of prescribing in Australia," they said.
"We acknowledge the long-standing concerns from the medical profession around potential fragmentation of care, conflicts of interest and clinical governance.
"These issues will be a key focus of the consultation and the Board's consideration in preparing a draft registration standard and guidelines for the consideration of Health Ministers," they stated.
The Board also noted Ahpra's recent update of the National Prescribing Competencies Framework, one of the guiding documents used for the education and regulation of prescribers and promotes best practice.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Nov 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Nov 25
